title: [The statement of Polish Gynecological Society Experts on the etiology and treatment of recurrent vulvovaginal candidiasis].
abstract: Vulvovaginal infection is the most common cause of gynecological problems in sexually active women. Knowledge about pharmacological properties of drugs used in treatment recurrent vulvovaginal candidiasis allows for tailoring therapy to each patient. Fluconazole is modern and up to date option for treatment of recurrent vulvovaginal candidiasis. Short- and long-term therapeutic efficacy of fluconazole was confirmed in numerous high reliability clinical trials. Good tolerance, high effectiveness and high level of patient's acceptance gives the specialist powerful and efficient tool for management of recurrent Candida infections.
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000302:isolation & purification; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole